NEW YORK (AP) — CVS Caremark says it will pay $5 million to resolve allegations that one of its subsidiaries understated the price of several drugs on a Medicare website.
The payment will be used to reimburse Medicare prescription drug beneficiaries who paid more than they expected for the drugs, and it ends an investigation by the Federal Trade Commission. CVS Caremark Corp. says its Rx America business accidentally published incorrect drug price information on a site maintained by Medicare.
In some cases, the actual prices were 10 times higher than the listed prices, the agency said.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
